SEC Form 4 · accession 0001104659-26-077771
Orchestra BioMed Holdings, Inc. · OBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Aryeh
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 25, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001814114
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.04 | Jun 23, 2026 | A | 42,553 | A | — | Jun 23, 2036 | Common Stock | 42,553 | 42,553 | D |
Explanation of responses
- F1The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date"), subject to the Reporting Person's continuous service through such date.